ESC Professional Premium Access

Challenges in transcatheter aortic valve intervention

Event: ESC Congress 2022
Topic: Valvular Heart Disease
Session type: Moderated ePosters
Date: 29 August 2022
Time: 11:15 - 12:00

Congress Session

5 presentations in this session

Man-machine interaction-based phenotyping preprocedurally identifies patients with severe aortic stenosis, who will not recover from cardiac damage following transcatheter aortic valve replacement

Speaker: Miss E. Rippen (Munich, DE)
Thumbnail

Phenotyping patients with aortic stenosis using cluster analysis to determine mortality and suitability for transcatheter aortic valve replacement

Speaker: Doctor J. Sen (Melbourne, AU)
Thumbnail

Prognostic relevance of mitral regurgitation at different follow-up timepoints after transcatheter aortic valve implantation (TAVI): implications for therapeutic decision making?

Speaker: Professor M. Franz (Jena, DE)
Thumbnail

Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR - a multicentre experience

Speaker: Doctor B. Al-Kassou (Bonn, DE)
Thumbnail

Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)

Speaker: Professor M. Franz (Jena, DE)
Thumbnail

5 speakers from this session

Miss Elena Rippen

, Munich (Germany)
0 follower

Doctor Jonathan Sen

Baker Heart and Diabetes Institute, Melbourne (Australia)
0 follower

Professor Marcus Franz

University Hospital Jena, Jena (Germany)
0 follower

Doctor Baravan Al-Kassou

University hospital Bonn, Bonn (Germany)
1 follower

Professor Marcus Franz

University Hospital Jena, Jena (Germany)
0 follower

This platform is supported by

logo Novo Nordisk